MedPath

A clinical study assessing the efficacy of the test product in maintaining long-lasting freshness of breath in healthy adult individuals experiencing oral malodour.

Not Applicable
Conditions
Health Condition 1: R196- Halitosis
Registration Number
CTRI/2024/05/067622
Lead Sponsor
aturelle LLC
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Age: 18 to 65 years (both inclusive) old at the time of consent in the following manner:

a.10 subjects aged 18 to 35 years

b.10 subjects aged 36 to 50 years

c.10 subjects aged 51 to 65 years

2)Sex: Healthy adult males and non-pregnant/non-lactating females.

3)Females of childbearing potential have a self-reported negative urine pregnancy test at the time of the screening visit and agree to follow an accepted method of birth control for the duration of the study such as condoms, foams, jellies, diaphragm, intrauterine device etc.

4)Subjects are generally in good general health as determined from recent medical history.

5)Subjects having score of 3 or more than 3 in Organoleptic assessment.

6)Subjects having score of 2 or more than 2 in assessment by Tanita.

7)Subjects having score of more than 140 ppb in Halimeter.

8)Subjects with no tooth sensitivity during screening.

9)No cervical lesions, or dental pain.

10)Subjects who agree to discontinue the use of over-the-counter breath freshness products (mouthwash, gargles, mouth spray, chewing gum, etc) throughout the trial.

11)Subjects who agree to discontinue the use of any other oral care product like mouth wash, oil pull, any medicated gargle, mouth sprays, any tooth gel or chewing gums etc. throughout the trial.

12)Subjects who consent to consume the food provided by the study site.

13)Agree not to participate in any other oral/dental product studies during the trial.

14)Agree to return for all scheduled visits and follow study procedures.

15)Subjects who are willing to complete all study procedures including study-related questionnaires and comply with study requirements.

16)Subjects who can read, sign, and receive a copy of informed consent before on of study procedures.

Exclusion Criteria

1)Subjects who are undergoing treatment for gingivitis, periodontitis, or caries.

2)Subjects are present with any pre-existing oral or medical condition that the Investigator/designee determines may place the subject at increased health risk from study participation.

3)Subjects who are Pan/Gutka eaters and smokers.

4)Subjects have teeth with severe or atypical intrinsic staining, such as that caused by tetracycline, fluorosis or hypo calcification.

5)Subjects have any known allergies to over-the-counter oral products.

6)Subjects have any known allergies to the trial product ingredients.

7)Any other condition which could warrant exclusion from the study, as per the investigator’s discretion.

8)Pregnant or breastfeeding or planning to become pregnant during the study period.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. To evaluate the effectiveness of the test product in terms of change in Halitosis from baseline using Halimeter. <br/ ><br>2. To assess the effectiveness of the test product in terms of change in Halitosis/malodour from baseline using Tanita. <br/ ><br>3. To evaluate the effectiveness of the test product in retaining freshness after 1st usage of the test product from baseline using organoleptic assessment scale by Dentist. <br/ ><br>Timepoint: 1. At Day 01 before test product usage and after test product usage at T0 plus 5 mins and T12 hours on Day 01 and on Day 28 (if applicable) <br/ ><br>2. At Day 01 before test product usage and after test product usage at T0 plus 5 mins, T13 hours, and T12 hours on Day 01 and on Day 28 (if applicable) <br/ ><br>3. At Day 01 before test product usage and after test product usage at T0 plus 5 mins, T13 hours, and T12 hours on Day 01 and on Day 28 (if applicable)
Secondary Outcome Measures
NameTimeMethod
To evaluate the effectiveness of the test product in terms of change subject perception questionnaires after test product usage, using the 5-point scoring scale.Timepoint: After usage of the test product at T0 at 5mins and T12 hours on Day 01 and on Day 28 (if applicable)
© Copyright 2025. All Rights Reserved by MedPath